SLC22A17 and B-cell chronic lymphocytic leukemia: Surface NGAL-R expression levels could be quantified for patient P16′s CLL cells before FCR treatment and at remission; the surface NGAL-R level was high before treatment but fell after treatment with FCR (Figure 3D).